Accordingly, in line with our in vitro findings on EPCs from type 2 diabetic patients, our in vivo findings suggested that CXCL5 was not just an indicator, which might impair rather than promote angiogenesis as well as wound healing in diabetic animals. Here, CXCL5 is linked to type 2 diabetes mellitus.